Purpose The aim of this clinical review was to summarise the existing knowledge on fall risk
associated with benzodiazepines (BZDs) and Z-drugs in older people with focus on …

There is growing evidence that chronic kidney disease (CKD) is an independent risk factor
for cognitive impairment, especially due to vascular damage, blood–brain barrier disruption …

Background Clinical practice guidelines and guidance documents routinely offer prescribing
clinicians' recommendations and instruction on the use of psychotropic drugs for mental …

Background Benzodiazepine use is common, particularly in older adults. Benzodiazepines
have well-established acute adverse effects on cognition, but long-term effects on …

Objectives To examine the association between prescription opioid use and the risk of
dementia in old-age, since existing studies of the association are few, and the evidence is …

Background Patients with young onset Alzheimer's disease (YOAD) face long diagnostic
delays. Prescription medication use may provide insights into early signs and symptoms …

Objectives: Older adults commonly take benzodiazepines (BZDs) that may have long-term
adverse cognitive effects. We investigated whether BZD use was related to developing mild …

Objective The lack of current Canadian practice guidelines for the management of insomnia
poses a challenge for healthcare providers (HCP) in selecting the appropriate treatment …

Aim We investigated the association of electroconvulsive therapy (ECT) with anxiolytic and
sleep medication use in patients with major depressive disorder (MDD) and schizophrenia …

Objective This narrative review aims to provide a comprehensive assessment of the existing
literature on the relationship between hypnotics and dementia, considering both potential …